ONWARD verstärkt Führungsteam auf Schlüsselpositionen in den Bereichen Clinical & Regulatory sowie Marketing
15 mars 2024 02h30 HE
|
ONWARD Medical NV
EINDHOVEN, Niederlande, LAUSANNE, Schweiz und BOSTON, MA, March 15, 2024 (GLOBE NEWSWIRE) -- Das Medizintechnikunternehmen ONWARD Medical N.V. (Euronext: ONWD), das innovative Therapien zur...
ONWARD renforce son management avec des nominations clés dans le domaine clinique et réglementaire et en marketing
15 mars 2024 02h30 HE
|
ONWARD Medical NV
EINDHOVEN, Pays-Bas, LAUSANNE, Suisse, et BOSTON, MA, Etats-Unis, 15 mars 2024 (GLOBE NEWSWIRE) -- ONWARD Medical SA (Euronext: ONWD), société de technologie médicale créant des thérapies innovantes...
ONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCI™ System
11 mars 2024 02h30 HE
|
ONWARD Medical NV
EINDHOVEN, the Netherlands, March 11, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore...
ONWARD® Medical Awarded 10th Breakthrough Device Designation for Brain-Computer Interface (BCI) from US FDA
29 févr. 2024 01h41 HE
|
ONWARD Medical NV
EINDHOVEN, the Netherlands, Feb. 29, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore...
KBC Securities Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 10.00 Per Share
09 févr. 2024 01h30 HE
|
ONWARD Medical NV
EINDHOVEN, the Netherlands, Feb. 09, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and...
ONWARD® MEDICAL ANNOUNCES PRESENTATION AT BIOCAPITAL EUROPE
07 févr. 2024 15h55 HE
|
ONWARD Medical NV
EINDHOVEN, the Netherlands, Feb. 07, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore...
ONWARD® ARC Therapy™ Highlighted at 2024 Annual Meeting of the North American Neuromodulation Society (NANS)
25 janv. 2024 17h11 HE
|
ONWARD Medical NV
EINDHOVEN, the Netherlands, Jan. 25, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and...
ONWARD® to Participate in Basel Healthtech Conference 2024
22 janv. 2024 14h03 HE
|
ONWARD Medical NV
EINDHOVEN, the Netherlands, Jan. 22, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore...
ONWARD® to Participate in Degroof Petercam Healthcare Conference
19 janv. 2024 12h48 HE
|
ONWARD Medical NV
EINDHOVEN, the Netherlands, Jan. 19, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore...
ONWARD® Announces Start of HemON NL Clinical Study
18 janv. 2024 01h30 HE
|
ONWARD Medical NV
EINDHOVEN, the Netherlands, Jan. 18, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore...